Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Low Dose Rivaroxaban in Patients With Anterior Myocardial Infarction

NCT05744804 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05744804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05744804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Low Dose Rivaroxaban in Patients With Anterior Myocardial Infarction
Lead sponsor
Sohag University
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2023
Completion date
December 1, 2023
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patient with anterior myocardial infarction